10 likes | 99 Views
Research shows that the Dscr1 gene is upregulated in Down's syndrome, leading to a suppression of tumor angiogenesis in affected tissues and models. This study sheds light on the potential therapeutic implications for cancer treatment in individuals with Down's syndrome.
E N D
Dscr1 expression is upregulated and tumour angiogenesis is suppressed in Down’s syndrome tissues and models. K-H Baek et al. Nature000, 1-5 (2009) doi:10.1038/nature08062